The Drug Enterprise in the Age of AI

AI is speeding up the search for new medicines. Can it make the discoveries themselves? Few people are better placed to answer than Dr. Elias Zerhouni. He ran the National Institutes of Health, then global R&D at Sanofi. He co-founded ModeX Therapeutics, which uses machine learning to design antibodies that don’t exist in nature, and…

Read More

Health Care in the 2026 Midterm Election

This dashboard focuses on KFF’s analysis of the role health care costs and other health policy issues played in voters’ decisions in the 2026 midterm elections, including in key Senate races. It examines the role of rising health costs on voters’ decisions, views on the Trump administration’s health care policies, and opinions on the government’s…

Read More

A Déjà Vu Moment for Women’s Health Research

In this column for Nature, Alina Salganicoff reviews efforts to improve women’s health research during previous U.S. administrations that fell short of their promise and highlights the recommendations of a congressionally mandated committee aimed at improving women’s health research at the National Institutes of Health.

Read More